Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid in CMT1A
NCT00484510Phase 3Completed
- Sponsor
- Wayne State University
- Start
- Apr 2007
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT1A), sponsored by Wayne State University. Started Apr 2007; status: completed.
02
Drugs
ascorbic acid
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)
Beyond the preview
Go deeper on NCT00484510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484510.